Use of smoking cessation pharmacotherapies during pregnancy is not associated with increased risk of adverse pregnancy outcomes: a population-based cohort study.
Saved in:
| Title: | Use of smoking cessation pharmacotherapies during pregnancy is not associated with increased risk of adverse pregnancy outcomes: a population-based cohort study. |
|---|---|
| Authors: | Tran, Duong Thuy1 (AUTHOR) Danielle.Tran@unsw.edu.au, Preen, David B.2 (AUTHOR), Einarsdottir, Kristjana3 (AUTHOR), Kemp-Casey, Anna4 (AUTHOR), Randall, Deborah5 (AUTHOR), Jorm, Louisa R.1 (AUTHOR), Choi, Stephanie K. Y.1 (AUTHOR), Havard, Alys1 (AUTHOR) |
| Source: | BMC Medicine. 2/5/2020, Vol. 18 Issue 1, p1-14. 14p. 1 Diagram, 3 Charts, 1 Graph. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 17417015 |
|---|---|
| DOI: | 10.1186/s12916-019-1472-9 |
